The lab leak hypothesis; incentives of drug regulators

My column in the Business Standard today is How might the lab leak hypothesis matter?

Drug regulation by state government agencies in India works poorly. The design of the objectives and incentives of these organisations determines their regulatory outcomes. Harleen Kaur, Shubho Roy, Siddhartha Srivastava and I have an article on The Leap Blog on 1 June, Incentive compatibility and state-level regulation in Indian drug quality where we examine the incentives of drug regulators and identify ways to improve these.